Favier, FR
Alain Favier, Nogent-Sur-Marne FR
Patent application number | Description | Published |
---|---|---|
20120011904 | ANTITHEFT DEVICE FOR MERCHANDISE INCLUDING MEANS FOR THE PLACEMENT AND SIMPLIFIED REMOVAL THEREOF - An antitheft device ( | 01-19-2012 |
20120102802 | DEVICE FOR MARKING AN ITEM WITH A VIEW TO IDENTIFYING SAME | 05-03-2012 |
20120285206 | THEFT-PREVENTION UNIT FOR A COMMERCIAL ITEM - A theft-prevention unit ( | 11-15-2012 |
20130118043 | Assembly for protecting an item against theft including a marking device having a variable display - An assembly for protecting an item against theft, includes a device ( | 05-16-2013 |
20140321900 | ASSEMBLY FOR PROTECTING AN ITEM OF MERCHANDISE AGAINST THEFT, WHICH CAN BE ASSEMBLED IN A TEMPORARY MANNER - Assembly for protecting a product against theft, includes a first part having a spike intended to pass through the product, and a second part provided in a first zone with an orifice for inserting the spike and locking elements to prevent the spike from being withdrawn after insertion. The second part includes at least one second zone for inserting the spike in a plurality of possible positions, the two parts are assembled with one another and kept in two possible modes of assembly. In a first protection mode, the spike is inserted into the orifice of the second part and the locking elements are activated so that a user cannot separate them without a tool; in a second temporary-assembly mode, the spike is inserted into the second zone and held therein in a temporary-assembly position such that a user can separate the two parts from one another without a tool. | 10-30-2014 |
20140373407 | SELF-CONTAINED VARIABLE DISPLAY DEVICE FOR MARKING AN ARTICLE - A device for marking an article with a view to identifying same includes an information display area, a medium for storing the information to be displayed ( | 12-25-2014 |
20150145680 | DEVICE FOR PROTECTING A COMMERCIAL ARTICLE AGAINST THEFT - A device for protecting a commercial article which is a physical object ( | 05-28-2015 |
20150187150 | SYSTEM AND METHOD FOR MANAGING THE UNLOCKING OF AN ANTI-THEFT DEVICE - A system for managing the unlocking of a device for identifying a commercial item includes at least two elements capable of assuming a locked position in which they enclose the article between them, and an unlocked position. The system includes a device for unlocking the identification device, elements for preventing unlocking, which are activated, and decision elements for deciding whether to deactivate or not deactivate the elements for preventing unlocking. The decision elements are capable of deciding on the basis of the identification or lack of identification of the association of the identification device and the commercial item to which the device is attached. | 07-02-2015 |
Alain Favier, Bernin FR
Patent application number | Description | Published |
---|---|---|
20110027807 | PROTEIN SPECIFIC TO PANCREATIC BETA CELLS IN ISLETS OF LANGERHANS AND APPLICATIONS THEREOF - The invention relates to protein ZnT-8 which is specifically expressed in the pancreatic beta cells in islets of Langerhans, to a polynucleotide encoding said protein which is involved in the maturation and exocytosis of insulin, and to the applications thereof, for example, for sorting and studying beta cells and for screening medicine acting on diabetes and hyperinsulinism. | 02-03-2011 |
Anne-Laure Favier, Latronche Cedex FR
Patent application number | Description | Published |
---|---|---|
20110171256 | VIRAL STRAINS DERIVED FROM THE VACCINIA VIRUS LISTER VACV-107 AND USES THEREOF - The present invention relates to viral strains derived from the vaccinia virus Lister VACV-107 and to pharmaceutical composition containing the viral strains. More particularly, the present invention relates to a viral strain derived from the vaccinia virus Lister VACV-107 wherein strain contains in its genomic sequence (SEQ ID N°1) at least one deletion selected from the group consisting of: deletion of the nucleotides 19758 to 28309 in the sequence ID NO°1 (Δ18), deletion of the nucleotides 161293 to 164811 in the sequence ID NO°1 (Δ20), deletion of the nucleotides 181231 to 183304 in the sequence ID NO°1 (Δ21), deletion of the nucleotides 6118 to 9677 in the sequence ID NO°1 (Δ22), deletion of the nucleotides 1833 to 3574 and 185848 to 187589 in the sequence ID NO°1 (Δ23). | 07-14-2011 |
Benoit Favier, Paris FR
Patent application number | Description | Published |
---|---|---|
20110268737 | HLA-G PROTEINS AND PHARMACEUTICAL USES THEREOF - The present invention relates to novel proteins and pharmaceutical uses thereof. The invention more specifically relates to novel fusion proteins comprising a domain of an HLA-G antigen fused to an Fc domain of an immunoglobulin. The invention also relates to methods of producing such polypeptides, pharmaceutical compositions comprising the same, as well as their uses for treating various diseases including organ/tissue rejection. | 11-03-2011 |
20110274711 | HLA-G POLYPEPTIDES AND PHARMACEUTICAL USES THEREOF - The present invention relates to novel proteins and pharmaceutical uses thereof The invention more specifically relates to novel proteins comprising the sequence of an HLA-5 antigen fused to the sequence of a b2 microglobulin. The invention also relates to methods of producing such polypeptides, pharmaceutical compositions comprising the same, as well as their uses for treating various diseases including organ/tissue rejection. | 11-10-2011 |
Bertrand Favier, St Vincent De Mercuze FR
Patent application number | Description | Published |
---|---|---|
20140315232 | METHOD FOR DOSING THE CONTROL CAPACITY OF C1INH - The present invention relates to a method for dosing the control capacity of plasma serpin (SERine Protease INhibitor) C1 inhibitor (C1Inh) on the basis of a patient blood sample. The invention also relates to a kit specially designed for said dosing. | 10-23-2014 |
Boris Favier, Lyon FR
Patent application number | Description | Published |
---|---|---|
20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
20110064773 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3′,5′,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle. | 03-17-2011 |
Cedric Favier, Saint Mars Du Desert FR
Patent application number | Description | Published |
---|---|---|
20140089536 | ADC SEQUENCING - A device comprises a central processing unit (CPU) and a memory configured for storing memory descriptors. The device also includes an analog-to-digital converter controller (ADC controller) configured for managing an analog-to-digital converter (ADC) using the memory descriptors. In addition, the device includes a direct memory access system (DMA system) configured for autonomously sequencing conversion operations performed by the ADC without CPU intervention by transferring the memory descriptors directly between the memory and the ADC controller for controlling the conversion operations performed by the ADC. | 03-27-2014 |
Cedric Favier, Nantes Cedex FR
Patent application number | Description | Published |
---|---|---|
20140359191 | ADC SEQUENCING - A device comprises a central processing unit (CPU) and a memory configured for storing memory descriptors. The device also includes an analog-to-digital converter controller (ADC controller) configured for managing an analog-to-digital converter (ADC) using the memory descriptors. In addition, the device includes a direct memory access system (DMA system) configured for autonomously sequencing conversion operations performed by the ADC without CPU intervention by transferring the memory descriptors directly between the memory and the ADC controller for controlling the conversion operations performed by the ADC. | 12-04-2014 |
Christine Favier, Marnes La Coquette FR
Patent application number | Description | Published |
---|---|---|
20120322098 | CULTURE MEDIUM FOR SCREENING OR ENRICHMENT OF METHICILLIN-RESISTANT S. AUREUS - The invention relates to culture medium for screening or enrichment of methicillin-resistant | 12-20-2012 |
Christine Favier, Wormhout FR
Patent application number | Description | Published |
---|---|---|
20130089883 | QUICK METHOD FOR DETECTING ENYZMES AND MICROORANISMS - The present invention concerns an in vitro method for detecting an enzyme or a microorganism in a biological sample, comprising the steps of: | 04-11-2013 |
20150211044 | QUICK METHOD FOR DETECTING ENYZMES AND MICROORGANISMS - The present invention concerns an in vitro method for detecting an enzyme or a microorganism in a biological sample, comprising the steps of: | 07-30-2015 |
Denis Favier, Saint Martin D'Uriage FR
Patent application number | Description | Published |
---|---|---|
20140257203 | DEVICE FOR GUIDING A MEDICAL NEEDLE - The invention relates to a device for guiding a medical needle, including said medical needle ( | 09-11-2014 |
Franck Favier, Lyon FR
Patent application number | Description | Published |
---|---|---|
20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
Frederic Favier, Saint Clement De Riviere FR
Patent application number | Description | Published |
---|---|---|
20150191834 | COMPOSITE ELECTRODES FOR THE ELECTROLYSIS OF WATER - An electrode is provided that is suitable for use with the electrolysis of water in a liquid electrolyte medium, the electrode formulated by the following formulation method: | 07-09-2015 |
Frederique Favier, Dardilly FR
Patent application number | Description | Published |
---|---|---|
20150121612 | HEAT RESISTANT OUTERSHELL FABRIC - The present invention relates to a thermally-resistant woven fabric and/or multiple ply fabric sheet for use as single or outer layer of protective garments, of the type comprising an inside fabric layer and an outside fabric layer joined together by an array of connecting lines. The woven fabric and/or multiple ply fabric sheet comprise yarns, wherein said yarn comprises | 05-07-2015 |
Georges Favier, Paris FR
Patent application number | Description | Published |
---|---|---|
20080196872 | Compact Water/Water Heat Pump Core, and Heat Pump Comprising Same - The whole set includes a compressor assembly ( | 08-21-2008 |
20090025902 | Probe For Collecting Thermal Energy From The Ground For A Heat Pump, And A Collection Network Equipped With Such Probes - The probe ( | 01-29-2009 |
20100293982 | HEATING AND AIR-CONDITIONING INSTALLATION WITH A HEAT PUMP, THE INSTALLATION INCLUDING AT LEAST ONE HEAT TRANSFER FLUID DISTRIBUTOR UNIT WITH COUPLING TO A PLURALITY OF HEAT COLLECTION AND DELIVERY CIRCUITS - The distributor unit ( | 11-25-2010 |
Isabelle Favier, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20160038926 | METAL NANO-CATALYSTS IN GLYCEROL AND APPLICATIONS IN ORGANIC SYNTHESIS - A catalytic system which is a suspension in glycerol of metal nanoparticles in at least one transition metal. The suspension also includes at least one compound stabilizing the metal nanoparticles, soluble in glycerol. The suspensions are obtained directly in glycerol. These are stable systems that can catalyse a reaction from an organic substrate, with high yields and activity, and excellent selectivity. Additionally, the use of the catalytic system for performing organic transformations such as hydrogenation or coupling reactions (formation of C—C, C—N, C—O, C—S . . . bonds), and for synthesizing polyfunctionnal molecules, in a single reactor, by multi-step, sequential or cascade reactions. | 02-11-2016 |
Jean-Jacques Favier, Montastruc La Conseillere FR
Patent application number | Description | Published |
---|---|---|
20110187860 | COMPRESSION OF EARTH OBSERVATION SATELLITE IMAGES - A method of acquiring, compressing and transmitting satellite images, characterized in that in a systematic manner: an image is acquired ( | 08-04-2011 |
20110206096 | METHOD AND SYSTEM FOR ACQUIRING AND REPATRIATING SATELLITE DATA - A method of acquiring and repatriating satellite data representative of a zone in space, termed the target zone, and an instrument for acquiring and repatriating satellite data including a plurality of satellites ( | 08-25-2011 |
Jean-Patrick Favier, Creteil Cedex FR
Patent application number | Description | Published |
---|---|---|
20120285208 | KEY HAVING A RETRACTABLE INSERT WITH IMPROVED MECHANICAL STRENGTH - The invention relates to a module for extending a retractable insert of a key, in particular for a motor vehicle, which is intended to be mounted in a casing for said key and which comprises an insert ( | 11-15-2012 |
Jérôme Favier, Saint Laurent Du Pont FR
Patent application number | Description | Published |
---|---|---|
20130175449 | INFRARED DETECTOR COMPRISING A PACKAGE INTEGRATING AT LEAST ONE DIFFRACTION GRATING - The infrared detector includes a sensitive retina capable of detecting a radiation in the wavelength range between 8 and 14 micrometers; and a package containing the sensitive retina and including a window located opposite to the retina, said window comprising a substrate at least partially transparent in the wavelength range between 2 and 14 micrometers; and a set of optical filters formed on the window to attenuate an incident radiation on the retina in a wavelength range between 2 and 8 micrometers, and respectively an optical filter formed on a first surface of the window and attenuating the incident radiation in a first interval of the wavelength range between 2 and 8 micrometers, and a periodic diffraction grating formed on a second surface of the window and attenuating the incident radiation in a second interval of the wavelength range between 2 and 8 micrometers, different from the first interval. | 07-11-2013 |
Maxime Favier, Bures Sur Yvette FR
Patent application number | Description | Published |
---|---|---|
20140168550 | POLARISATION ROTATOR WITH SMALL INDUCED ELLIPTICITY - The invention relates to a polarisation rotator with small polarisation ellipticity. The rotator includes a first optical unit ( | 06-19-2014 |
Michelle Favier, Jonage FR
Patent application number | Description | Published |
---|---|---|
20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
20110064773 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3′,5′,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle. | 03-17-2011 |
Pascale Favier, Beaumont FR
Patent application number | Description | Published |
---|---|---|
20130095343 | SHEET METAL PLATE WITH RELIEFS FOR CREATING INDUSTRIAL FLOORING OVER WHICH TRUCKS ARE TO RUN, ENGRAVED CYLINDER FOR OBTAINING SUCH SHEET METAL PLATES BY ROLLING - Sheet metal plate for creating flooring, particularly of industrial vehicles, over which trucks are to run, having a plurality of patterns, the maximum height of said reliefs ranging between 0.2 and 1.5 mm, said reliefs having a friction surface which has a mean width of at least 1 mm, in which said reliefs are arranged in a plurality of aligned groups of reliefs all of the same shape, the same orientation, and with their centers of gravity substantially aligned in one and the same given direction (D), the minimum distance, measured in said direction (D), between two adjacent reliefs of one and the same aligned group being less than 6 mm. The direction (D) in which the aligned groups are aligned advantageously coincides with the direction (De) in which the trucks run. | 04-18-2013 |
Rémi Favier, Sceaux FR
Patent application number | Description | Published |
---|---|---|
20130344494 | MYH10 AS A NEW MARKER OF PATHOLOGIES RESULTING FROM RUNX1 INACTIVATION - A method of diagnosing a pathology resulting from a runt-related transcription factor 1 (RUNX1) inactivation in a subject, which includes the step of i) determining the platelets' myosin non-muscle heavy chain 10 (MYH10) expression level in a biological sample from the subject, and wherein a detectable platelets' MYH10 expression level is indicative of a pathology resulting from a runt-related transcription factor 1 (RUNX1) inactivation, and to a kit for diagnosing a pathology resulting from a runt-related transcription factor 1 (RUNX1) inactivation in a subject including i) at least one antibody for determining the platelet MYH10 expression level in a biological sample from the subject, which can be used in a such a method. | 12-26-2013 |
20150232932 | ANKRD26 AS A MARKER FOR DIAGNOSIS OF THROMBOCYTOPENIAS - An in vitro method for diagnosing thrombocytopenia in a subject, the method includes the step of assessing the ANKRD26 platelet expression in a biological sample from the subject, wherein a ANKRD26 platelet expression is indicative of a thrombocytopenia. Also described is a kit for diagnosing a thrombocytopenia in a subject, which includes at least one ANKRD26 nucleic acid probe or oligonucleotide or antibody for assessing the ANKRD26 platelet expression in a biological sample from the subject. | 08-20-2015 |
Roland Favier, Jonage FR
Patent application number | Description | Published |
---|---|---|
20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
20110064773 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3′,5′,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle. | 03-17-2011 |
Yann Favier, Jonage FR
Patent application number | Description | Published |
---|---|---|
20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
20110064773 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3′,5′,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle. | 03-17-2011 |